secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001193125-23-154219
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix stockholders elect three directors, ratify KPMG, approve option exchange at 2023 annual meeting
--------------------------------------------------------------------------------

- All three Class III director nominees (Jean Franchi, Hany Massarany, Jack Schuler) elected with >62M votes each.
- Ratification of KPMG as independent auditor for FY2023 passed: 71.4M for, 95,555 against, 28,164 abstentions.
- Stock option exchange program approved: 60.4M for, 4.2M against, 19,570 abstentions, 6.9M broker non-votes.
- Record date March 24, 2023; 77,979,011 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/0001193125-23-154219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/d448589d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-154219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer